The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Recombinant Antibody-Global Market Insights and Sales Trends 2025
Synopsis
Recombinant antibodies are antibodies produced through genetic engineering techniques, often using mammalian cells or other expression systems. They are used in research, diagnostics, and therapeutics.
The global Recombinant Antibody market size is expected to reach US$ 216.8 million by 2029, growing at a CAGR of 8.9% from 2023 to 2029. The market is mainly driven by the significant applications of Recombinant Antibody in various end use industries. The expanding demands from the Hospital, Scientific Research and Others,, are propelling Recombinant Antibody market. Chimeric Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Humanized Antibody segment is estimated at % CAGR for the next seven-year period.
The market for recombinant antibodies is growing due to their versatility in applications, including cancer therapy, autoimmune disease treatment, and targeted drug delivery. Advances in antibody engineering and production technologies are contributing to this trend.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Recombinant Antibody, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Recombinant Antibody market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Recombinant Antibody market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Recombinant Antibody sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Recombinant Antibody covered in this report include Abnova, Medix Biochemica, GE Healthcare, SinoBiological and Bioventix, etc.
The global Recombinant Antibody market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix
Global Recombinant Antibody market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Antibody market, Segment by Type:
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody
Global Recombinant Antibody market, by Application
Hospital
Scientific Research
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Recombinant Antibody companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Recombinant antibodies are antibodies produced through genetic engineering techniques, often using mammalian cells or other expression systems. They are used in research, diagnostics, and therapeutics.
The global Recombinant Antibody market size is expected to reach US$ 216.8 million by 2029, growing at a CAGR of 8.9% from 2023 to 2029. The market is mainly driven by the significant applications of Recombinant Antibody in various end use industries. The expanding demands from the Hospital, Scientific Research and Others,, are propelling Recombinant Antibody market. Chimeric Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Humanized Antibody segment is estimated at % CAGR for the next seven-year period.
The market for recombinant antibodies is growing due to their versatility in applications, including cancer therapy, autoimmune disease treatment, and targeted drug delivery. Advances in antibody engineering and production technologies are contributing to this trend.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Recombinant Antibody, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Recombinant Antibody market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Recombinant Antibody market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Recombinant Antibody sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Recombinant Antibody covered in this report include Abnova, Medix Biochemica, GE Healthcare, SinoBiological and Bioventix, etc.
The global Recombinant Antibody market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix
Global Recombinant Antibody market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Antibody market, Segment by Type:
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody
Global Recombinant Antibody market, by Application
Hospital
Scientific Research
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Recombinant Antibody companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Recombinant Antibody
1.1 Recombinant Antibody Market Overview
1.1.1 Recombinant Antibody Product Scope
1.1.2 Recombinant Antibody Market Status and Outlook
1.2 Global Recombinant Antibody Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Recombinant Antibody Market Size by Region (2018-2029)
1.4 Global Recombinant Antibody Historic Market Size by Region (2018-2023)
1.5 Global Recombinant Antibody Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Recombinant Antibody Market Size (2018-2029)
1.6.1 North America Recombinant Antibody Market Size (2018-2029)
1.6.2 Europe Recombinant Antibody Market Size (2018-2029)
1.6.3 Asia-Pacific Recombinant Antibody Market Size (2018-2029)
1.6.4 Latin America Recombinant Antibody Market Size (2018-2029)
1.6.5 Middle East & Africa Recombinant Antibody Market Size (2018-2029)
2 Recombinant Antibody Market by Type
2.1 Introduction
2.1.1 Chimeric Antibody
2.1.2 Humanized Antibody
2.1.3 Full Human Antibody
2.1.4 Single Chain Antibody
2.1.5 Bispecific Antibody
2.2 Global Recombinant Antibody Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Recombinant Antibody Historic Market Size by Type (2018-2023)
2.2.2 Global Recombinant Antibody Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Recombinant Antibody Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Recombinant Antibody Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Recombinant Antibody Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Recombinant Antibody Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Recombinant Antibody Revenue Breakdown by Type (2018-2029)
3 Recombinant Antibody Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Scientific Research
3.1.3 Others
3.2 Global Recombinant Antibody Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Recombinant Antibody Historic Market Size by Application (2018-2023)
3.2.2 Global Recombinant Antibody Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Recombinant Antibody Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Recombinant Antibody Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Recombinant Antibody Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Recombinant Antibody Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Recombinant Antibody Revenue Breakdown by Application (2018-2029)
4 Recombinant Antibody Competition Analysis by Players
4.1 Global Recombinant Antibody Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Antibody as of 2022)
4.3 Date of Key Players Enter into Recombinant Antibody Market
4.4 Global Top Players Recombinant Antibody Headquarters and Area Served
4.5 Key Players Recombinant Antibody Product Solution and Service
4.6 Competitive Status
4.6.1 Recombinant Antibody Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abnova
5.1.1 Abnova Profile
5.1.2 Abnova Main Business
5.1.3 Abnova Recombinant Antibody Products, Services and Solutions
5.1.4 Abnova Recombinant Antibody Revenue (US$ Million) & (2018-2023)
5.1.5 Abnova Recent Developments
5.2 Medix Biochemica
5.2.1 Medix Biochemica Profile
5.2.2 Medix Biochemica Main Business
5.2.3 Medix Biochemica Recombinant Antibody Products, Services and Solutions
5.2.4 Medix Biochemica Recombinant Antibody Revenue (US$ Million) & (2018-2023)
5.2.5 Medix Biochemica Recent Developments
5.3 GE Healthcare
5.3.1 GE Healthcare Profile
5.3.2 GE Healthcare Main Business
5.3.3 GE Healthcare Recombinant Antibody Products, Services and Solutions
5.3.4 GE Healthcare Recombinant Antibody Revenue (US$ Million) & (2018-2023)
5.3.5 SinoBiological Recent Developments
5.4 SinoBiological
5.4.1 SinoBiological Profile
5.4.2 SinoBiological Main Business
5.4.3 SinoBiological Recombinant Antibody Products, Services and Solutions
5.4.4 SinoBiological Recombinant Antibody Revenue (US$ Million) & (2018-2023)
5.4.5 SinoBiological Recent Developments
5.5 Bioventix
5.5.1 Bioventix Profile
5.5.2 Bioventix Main Business
5.5.3 Bioventix Recombinant Antibody Products, Services and Solutions
5.5.4 Bioventix Recombinant Antibody Revenue (US$ Million) & (2018-2023)
5.5.5 Bioventix Recent Developments
6 North America
6.1 North America Recombinant Antibody Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Recombinant Antibody Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Recombinant Antibody Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Recombinant Antibody Market Dynamics
11.1 Recombinant Antibody Industry Trends
11.2 Recombinant Antibody Market Drivers
11.3 Recombinant Antibody Market Challenges
11.4 Recombinant Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
